Hemoglobin-based oxygen carriers: Compassionate use and compassionate clinical trials

Anesthesia and Analgesia

Volumn 110, Issue 3, 2010, Pages 659-662

  Weiskopf, Richard B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; HEMOSPAN; POLYMERIZED HEMOGLOBIN; RECOMBINANT HEMOGLOBIN; UNCLASSIFIED DRUG;

ANEMIA; DRUG APPROVAL; DRUG EFFICACY; DRUG HALF LIFE; DRUG RESEARCH; DRUG SAFETY; EDITORIAL; GASTROINTESTINAL SYMPTOM; GOVERNMENT REGULATION; HEALTH CARE ACCESS; HEALTH CARE POLICY; HEALTH PROGRAM; HEART MUSCLE INJURY; HUMAN; HYPERTENSION; ISCHEMIA; LIVER CELL DAMAGE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

EID: 77949286474     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e3181c85255     Document Type: Editorial

References (37)

1. Mackenzie CF, Moon-Massat PF, Shander A, Javidroozi A, Greenburg G. When blood is not an option: factors affecting survival after use of a hemoglobin-based oxygen carrier in 54 patients with life-threatening anemia. Anesth Analg 2010;110:685-693
2. Food and Drug Administration. 21 CFR Parts 312 and 316: Expanded access to investigational drugs for treatment use. 2009: 74FR40900
3. Food and Drug Administration. 21CFR 56.104: institutional review boards. Exemptions from IRB requirement. 2002
4. Viele MK, Weiskopf RB. What can we learn about the need for transfusion from patients who refuse blood? The experience with Jehovah's Witnesses. Transfusion 1994;34:396-401
5. Carson JL, Duff A, Poses RM, Berlin JA, Spence RK, Trout R, Noveck H, Strom BL. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 1996;348:1055-1060 (Pubitemid 26343599)
6. Carson JL, Poses RM, Spence RK, Bonavita G. Severity of anaemia and operative mortality and morbidity. Lancet 1988;1:727-729 (Pubitemid 18075693)
7. Spahn DR, van Brempt R, Theilmeier G, Reibold JP, Weite M, Heinzerling H, Birck KM, Keipert PE, Messmer K. Perflubron emulsion delays blood transfusions in orthopedic surgery. Anesthesiology 1999;91:1195-1208 (Pubitemid 29506080)
8. Cheng DC, Mazer CD, Martineau R, Ralph-Edwards A, Karski J, Robblee J, Finegan B, Hall RI, Latimer R, Vuylsteke A. A phase II dose-response study of hemoglobin raffimer (Hemolink) in elective coronary artery bypass surgery. J Thorac Cardiovasc Surg 2004;127:79-86 (Pubitemid 38160469)
9. Greenburg AG, Kim HW. Use of an oxygen therapeutic as an adjunct to intraoperative autologous donation to reduce transfusion requirements in patients undergoing coronary artery bypass graft surgery. J Am Coll Surg 2004;198:373-83; discussion 384-385
10. Levy JH, Goodnough LT, Greilich PE, Parr GV, Stewart RW, Gratz I, Wahr J, Williams J, Comunale ME, Doblar D, Silvay G, Cohen M, Jahr JS, Vlahakes GJ. Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: results of a randomized, double-blind trial. J Thorac Cardiovasc Surg 2002;124:35-42
11. Sloan EP, Koenigsberg M, Gens D, Cipolle M, Runge J, Mallory MN, Rodman G Jr. Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial. JAMA 1999;282:1857-1864
12. Moore EE, Moore FA, Fabian TC, Bernard AC, Fulda GJ, Hoyt DB, Duane TM, Weireter LJ Jr, Gomez GA, Cipolle MD, Rodman GH Jr, Malangoni MA, Hides GA, Omert LA, Gould SA. Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA multicenter trial. J Am Coll Surg 2009;208:1-13
13. Food and Drug Administration. 21CFR50.24: Protection of human subjects; informed consent. Exception from informed consent requirements for emergency research. 2007
14. Resta TC, Walker BR, Eichinger MR, Doyle MP. Rate of NO scavenging alters effects of recombinant hemoglobin solutions on pulmonary vasoreactivity. J Appl Physiol 2002;93:1327-1336
15. Viele M, Weiskopf R, Fisher D. Renal effects and pharmacokinetics of recombinant human hemoglobin. Anesthesiology 1997;86:848-858
16. Hoffman SJ, Looker DL, Roehrich JM, Cozart PE, Durfee SL, Tedesco JL, Steuer GL. Expression of fully functional tetrameric human hemoglobin in Escherichia coli. Proc Natl Acad Sci USA 1990;87:8521-8525
17. Looker D, Abbott-Brown D, Cozart P, Durfee S, Hoffman S, Mathews A, Miller-Roehrich J, Shoemaker S, Trimble S, Fermi G. A human recombinant haemoglobin designed for use as a blood substitute. Nature 1992;356:258-260
18. Olofsson C, Nygards EB, Ponzer S, Fagrell B, Przybelski R, Keipert PE, Winslow N, Winslow RM. A randomized, singleblind, increasing dose safety trial of an oxygen-carrying plasma expander (Hemospan) administered to orthopaedic surgery patients with spinal anaesthesia. Transfus Med 2008;18:28-39 (Pubitemid 351239315)
19. Silverman TA, Weiskopf RB; Planning Committee and the Speakers. Hemoglobin based oxygen carriers: current status and future directions. Anesthesiology 2009;111:946-963
20. Silverman TA, Weiskopf RB; Planning Committee and the Speakers. Hemoglobin based oxygen carriers: current status and future directions. Transfusion 2009;49:2495-2515
21. Natanson C, Kern SJ, Lurie P, Banks SM, Wolfe SM. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis. JAMA 2008;299:2304-2312 (Pubitemid 351724397)
22. Burhop K, Gordon D, Estep T. Review of hemoglobin-induced myocardial lesions. Artif Cells Blood Substit Immobil Biotechnol 2004;32:353-374
23. Hermann J, Corso C, Messmer KF. Resuscitation with recombinant hemoglobin rHb2.0 in a rodent model of hemorrhagic shock. Anesthesiology 2007;107:273-280 (Pubitemid 47196491)
24. Malhotra AK, Kelly ME, Miller PR, Hartman JC, Fabian TC, Proctor KG. Resuscitation with a novel hemoglobin-based oxygen carrier in a Swine model of uncontrolled perioperative hemorrhage. J Trauma 2003;54:915-924
25. Raat NJ, Liu JF, Doyle MP, Burhop KE, Klein J, Ince C. Effects of recombinant-hemoglobin solutions rHb2.0 and rHb1.1 on blood pressure, intestinal blood flow, and gut oxygenation in a rat model of hemorrhagic shock. J Lab Clin Med 2005;145:21-32 (Pubitemid 40139074)
26. Takahata S, Konomi H, Schloithe AC, Toouli J, Saccone GT. Second-generation recombinant hemoglobin molecules do not stimulate sphincter of Oddi, gallbladder or duodenal motility in the Australian brush-tailed possum. Can J Gastroenterol 2004;18:441-448 (Pubitemid 39173352)
27. Hartman JC, Argoudelis G, Doherty D, Lemon D, Gorczynski R. Reduced nitric oxide reactivity of a new recombinant human hemoglobin attenuates gastric dysmotility. Eur J Pharmacol 1998;363:175-178 (Pubitemid 29057765)
28. von Dobschuetz E, Hutter J, Hoffmann T, Messmer K. Recombinant human hemoglobin with reduced nitric oxide-scavenging capacity restores effectively pancreatic microcirculatory disorders in hemorrhagic shock. Anesthesiology 2004;100:1484-1490 (Pubitemid 38679318)
29. Villagra J, Shiva S, Hunter LA, Machado RF, Gladwin MT, Kato GJ. Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin. Blood 2007;110: 2166-2172 (Pubitemid 47443936)
30. Federal Food and Cosmetic Act (FD&C Act)
31. Food and Drug Administration. 21CFR50: Protection of human subjects; informed consent; proposed rule. 1995:60FR49086
32. Food and Drug Administration. 21CFR50: Protection of human subjects; informed consent and waiver of informed consent requirements in certain emergency research; final rules. 1996:61FR51409
33. The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. Bethesda, MD: U.S. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, 1978
34. World Medical Association: Declaration of Helsinki. Br Med J 1966;313:1448-1449
35. Weiskopf R. Volunteer studies in anesthesia. In: Zbinden A, Thomson D, eds. Conducting research in anesthesia and intensive care medicine. London: Butterworth-Heinemann, 2001
36. The Nuremberg Code. Trials of war criminals before the Nuremberg Military Tribunals under control Council Law No. 10. Washington, DC: U.S. Government Printing Office, 1949:181-182
37. Mill JS. Utilitarianism. 2nd ed. Indianapolis, IN: Hackett Publishing Company, 2001 [original publication: 1861]